Medical/Pharmaceuticals

Everest Medicines Announces Financial Results for Full Year Ended December 31, 2024

SHANGHAI, March 26, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced its financial results for ...

2025-03-26 11:03 8362

Kelun-Biotech's Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors

CHENGDU, China, March 26, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the investigational new drug application for a radionuclide-drug conjugate (RDC) drug SKB107 (formerly TBM-00...

2025-03-26 10:45 2006

Fosun Pharma Announces 2024 Annual Results

Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH, 02196.HK), a leading global pharmaceutica...

2025-03-26 10:29 2933

CStone to Showcase Five Latest Research Achievements at AACR 2025

SUZHOU, China, March 25, 2025 /PRNewswire/ -- From April 25 to 30, 2025, the American Association for Cancer Research (AACR) Annual Meeting will take place inChicago. CStone will showcase its latest preclinical studies on five internally developed innovative candidates, including the trispecific ...

2025-03-26 08:15 2115

Alma introduces Alma Harmony, a state-of-the-art aesthetic platform for next-level in-office treatments

Featuring a simply intelligence interface and substantial technological upgrades, the new multiplatform presents a new era in patient personalization CAESAREA, Israel, March 26, 2025 /PRNewswire/ -- Alma Lasers , a Sisram Medical company and a global leader in energy-bas...

2025-03-26 07:29 2212

Complete Genomics Announces Partnership with BioTuring and the Go Optical STOmics microscope.

SAN JOSE, Calif., March 25, 2025 /PRNewswire/ -- Complete Genomics , a leading innovator in genomic sequencing, announced at theNextGen Omics & Spatial Biology Conference  that it has pa...

2025-03-25 21:00 1840

AccurEdit Therapeutics' LNP-based In Vivo Gene Editing Product ART001 Obtained Orphan Drug Designation from the FDA

CAMBRIDGE, Mass., March 25, 2025 /PRNewswire/ -- AccurEdit Therapeutics today announced that its innovativein vivo gene editing product, ART001, has obtained Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA). ART001, which utilizes lipid nanoparticle (LNP) technolog...

2025-03-25 19:00 1847

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

BASEL, Switzerland, March 25, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families, today announced the appointment of Dr. Constance Höfer as its new Chief Sci...

2025-03-25 19:00 1929

3Shape Unveils Revolutionary TRIOS 6 Intraoral Scanner and TRIOS Dx Plus Diagnostic Software at IDS

COPENHAGEN, Denmark, March 25, 2025 /PRNewswire/ -- 3Shape today proudly introduces its revolutionary TRIOS 6 intraoral scanner, Diagnostic software - TRIOS Dx Plus*, and the DentalHealth patient app. The new TRIOS 6 intraoral scanner not only incorporates several new upgrades, including hypersp...

2025-03-25 18:51 1934

WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025

* Revenue grew 9.6% YoY to RMB 18,675.4 million, with non-COVID revenue up 13.1% YoY * Adjusted EBITDA grew 14.4% YoY to RMB7,999.3 million and Adjusted Net Profit increased 9.0% YoY toRMB5,396.9 million * Added 151 new integrated projects, including 13 in late-stage and commercial stage ...

2025-03-25 18:30 2849

Rare loss-of-function variants in HECTD2 and AKAP11 confer a risk of bipolar disorder

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare loss-of-function variants in two genes and bipolar disorder. REYKJAVIK, Iceland, March 25, 2025 /PRNewswire/ -- Bipolar disorder is characterized by extreme mood swings, bouts of mania...

2025-03-25 18:00 2769

Medit Launches Medit i900 classic, a New Addition to Medit i900 Family Line Up

SEOUL, South Korea and NEWPORT BEACH, Calif., March 25, 2025 /PRNewswire/ -- Medit (www.medit.com ), a global leader in digital dentistry, is unveiling its latest scanner, the Mediti900 classic, as part of the Mediti900 Family. Launched on March 25, the Medit i900 classic p...

2025-03-25 15:00 3388

meerecompany enhances Korea-Vietnam medical exchange with Revo-i fellowship program

- Launch of SSC program to provide advanced robotic surgery training in Korea - Dr. Cao from Viet Tiep Friendship Hospital in Vietnam completed training at Severance Hospital SEOUL, South Korea, March 25, 2025 /PRNewswire/ -- meerecompany (CEO: Joon Koo Kim) announced today that its Revo-i surgi...

2025-03-25 10:00 2109

Exceptional Performance for Ureteral Stents: ICP DAS-BMP Reveals Latest TPU Materials at CMEF 2025

HSINCHU, March 25, 2025 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a committedTaiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is excited to announce its participation in CMEF (China International Medical Equipment Fair), held fromApril 8-11, 2025,...

2025-03-25 09:45 2466

Henlius 2024 Annual Results: Steady Revenue Growth with a Net Profit of RMB820.5 million, Up by 50.3% YoY

SHANGHAI, March 24, 2025 /PRNewswire/ -- Henlius (2696.HK) announced its 2024 annual results. During the reporting period, Henlius' total revenue reached approximatelyRMB5.7244 billion, representing an increase of 6.1% YoY. The net profit reachedRMB820.5 million, a 50.3% YoY growth, with a net pr...

2025-03-24 23:09 3237

Henlius 2024 Annual Results: Steady Revenue Growth with a Net Profit of RMB820.5 million, Up by 50.3% YoY

SHANGHAI, March 24, 2025 /PRNewswire/ -- Henlius (2696.HK) announced its 2024 annual results. During the reporting period, Henlius' total revenue reached approximatelyRMB5.7244 billion, representing an increase of 6.1% YoY. The net profit reachedRMB820.5 million, a 50.3% YoY growth, with a net pr...

2025-03-24 22:54 3510

WuXi XDC Achieved Another Remarkable Year with Extraordinary Business Performance and Financial Results for 2024

* Revenue increased by 90.8% YoY to RMB 4,052 million * Gross profit grew by 121.6% YoY to RMB 1,240 million, with its margin of 30.6%, a 4.3 percentage points increase compared to that of 2023 * Net profit surged by 277.2% YoY to RMB 1,070 million, with its margin of 26.4%, a 13.0 percentag...

2025-03-24 22:45 3354

Sermonix and Regor Announce Strategic Collaboration to Optimize Regor's Proprietary rCARD Platform for Identification of Novel Targets and Therapeutics

Partnership aims to develop efficacious and well-tolerated treatments for advanced metastatic breast cancer COLUMBUS, Ohio, and CAMBRIDGE, Mass., March 24, 2025 /PRNewswire/ -- Sermonix Pharmaceuticals, a privately held biopharmaceutical company developing innovative therapeutics to specifically...

2025-03-24 22:30 1857

Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120

Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research FREMONT, Calif., March 24, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announc...

2025-03-24 21:11 2121

Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval

NEW YORK, March 24, 2025 /PRNewswire/ -- On March 17, 2025, US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical—an innovative biopharmaceutical company incubated by Beijing Hotgen Biotech Co., Ltd. (SH.688068)—received Fast Track Des...

2025-03-24 21:00 1626
1 ... 108109110111112113114 ... 646